Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VILDAGLIPTIN vs VISIPAQUE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VILDAGLIPTIN vs VISIPAQUE: Safety Overview

Metric VILDAGLIPTIN VISIPAQUE
Total FAERS Reports 2,063 136
Deaths Reported 181 3
Death Rate 8.8% 2.2%
Hospitalizations 1,064 40
Average Patient Age 70.8 yrs 58.0 yrs
% Female Patients 49.6% N/A